ELAN FY 2020 Earnings — Elanco Animal Health Incorporated Revenue & Financial Results | Market Cap Arena

ELANElanco Animal Health Incorporated

$12B

FY 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$3.3B+6.6% YoY

Gross Profit

$1.2B38.1% margin

Operating Income

-$77M-2.3% margin

Net Income

-$560M-17.1% margin

EPS (Diluted)

$-1.27

Cash Flow

Operating Cash Flow

-$41M

Free Cash Flow

-$352M

Stock-Based Comp.

$47M

Balance Sheet

Total Assets

$17.7B

Total Liabilities

$9.2B

Stockholders' Equity

$8.5B

Cash & Equivalents

$495M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3.3B	$3.1B	+6.6%
Gross Profit	$1.2B	$1.4B	-11.0%
Operating Income	-$77M	$370M	-120.8%
Net Income	-$560M	$68M	-924.9%